CK Life Sciences Int'l. (Holdings) Balance Sheet Health
Financial Health criteria checks 1/6
CK Life Sciences Int'l. (Holdings) has a total shareholder equity of HK$4.2B and total debt of HK$5.4B, which brings its debt-to-equity ratio to 129.4%. Its total assets and total liabilities are HK$11.2B and HK$7.1B respectively. CK Life Sciences Int'l. (Holdings)'s EBIT is HK$223.8M making its interest coverage ratio 0.7. It has cash and short-term investments of HK$676.2M.
Key information
129.4%
Debt to equity ratio
HK$5.42b
Debt
Interest coverage ratio | 0.7x |
Cash | HK$676.16m |
Equity | HK$4.19b |
Total liabilities | HK$7.06b |
Total assets | HK$11.25b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: LSI's short term assets (HK$3.0B) exceed its short term liabilities (HK$2.1B).
Long Term Liabilities: LSI's short term assets (HK$3.0B) do not cover its long term liabilities (HK$5.0B).
Debt to Equity History and Analysis
Debt Level: LSI's net debt to equity ratio (113.3%) is considered high.
Reducing Debt: LSI's debt to equity ratio has increased from 109% to 129.4% over the past 5 years.
Debt Coverage: LSI's debt is not well covered by operating cash flow (9.5%).
Interest Coverage: LSI's interest payments on its debt are not well covered by EBIT (0.7x coverage).